Phase 1 N=5 Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp
Vulvovaginal Candidiasis · Candida Infection · Vaginal Candidiasis
Primary: SCY-078 Breast Milk Concentrations. — 0; 37.64; 72.22; 43.85 ng/mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=114 Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy
Thyroid Neoplasms · Thyroid Diseases · Hypoparathyroidism
Primary: The Average Number of Parathyroid Glands Identified (Experimental Group: Glands Identified With Naked Eye + NIRAF; Control Group: Glands Identified With Naked Eye) Per…
N/A N=4,379 School-Based Mental Health Effectiveness Study
Child Development
Primary: Teacher Knowledge of Evidence-Based Practice (Knowledge Score) — 36.68; 36.41; 35.18 score on a scale
N/A N=288 Non-Interventional Study to Describe the Clinical Management in Asthmatic Patients (NICMA)
Asthma
Primary: Clinical Management in Asthmatic Patients — 60; 64; 29; 41 Participants
N/A N=395 Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya
HIV Prevention
Primary: cRCT: PrEP Initiation — 41; 41 Participants
N/A N=186 Couple-Based Motivational Interviewing With Mobile Breathalyzers to Reduce Alcohol Use in South Africa
HIV/AIDS · Alcohol Abuse
Primary: Enrollment Rate — 31; 31; 30; 30 Participants
N/A N=41 Cardiovascular Responses to Heat Waves in the Elderly
Aging · Hyperthermia
Primary: Change in Core Body Temperature — .68; 1.37; .58; 1.02 degrees Celsius (°C)
Phase 2 N=30 Stress Response and Neurodevelopmental Outcome After Cardiac Surgery Utilizing CPB in Children: A Prospective, Double Blinded and Randomized Study
Congenital Heart Disease
Primary: Change in Cytokine Levels — 4.38; 4.2; 3.98; 3.85 picograms per milliliter
N/A N=101 Open Versus Robotic Retromuscular Ventral Hernia Repair
Ventral Hernia
Primary: Composite Outcome of Diagnosis of Surgical Site Occurrence or Infection, Hospital Readmission, or Hernia Recurrence — 9; 9 Participants
Phase 2 N=35 Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control
Photorefractive Keratectomy · Myopia · Hyperopia
Primary: Pain as Recorded by the FACES Scale (Maximum) After First Surgery — 1.33; 1.27 units on a scale — p=0.538
Phase 1 N=23 Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer
Breast Neoplasms
Primary: Dose-limiting Toxicities During the First 4 Weeks of Treatment — 0 participants
Phase 2 N=51 Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Glioma · Glioblastoma
Primary: Kaplan-Meier Estimate of Overall Survival (OS) at 9 Months — 67; 67 percentage of participants-Kaplan Meier
N/A N=85 Optimizing Provider Training in Eating Disorders (OPTED)
Anorexia Nervosa · Atypical Anorexia Nervosa
Primary: Number of Participants Who Complete Training — 48; 22; 8; 7 Participants — p=0.47
N/A N=479 COVID-19 Observational Research Collaboratory
COVID-19 · SARS-CoV-2 Infection
Primary: Instrumental Activities of Daily Living and Activities of Daily Living (I/ADL) Score — 3.40; 3.05; 3.50; 3.40 I/ADL Score — p=0.77
N/A N=97 Re-engagement at Discharge 2
HIV/AIDS · Hospitalization · Transitions of Care
Primary: Post-Discharge Visits — 92 Participants